Riskpilot← Back to searchSign inGet full accessMEYER MED AS
ASActiveOrg 874534862Krøderfjordveien 1411, 3536 NoresundBuying and selling of own real estate · NACE 6811Est. 19950 employees
Revenue 2024
NOK 0
EBITDA margin
—
+33% vs 2023
Equity ratio
74.3%
Financial strength
Net profit 2024
NOK 417K
-1% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -332K | +33% |
| Net profit | NOK 417K | -1% |
| Total assets | NOK 14,8M | -2% |
| Equity | NOK 11M | -25% |
| Employees | 0 | — |
Legal name
MEYER MED AS
Org number
874534862
Legal form
Aksjeselskap
NACE code
6811 · Buying and selling of own real estate
Founded
2. januar 1995
Share capital
NOK 71 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utøve investeringsvirksomhet, herunder kjøp/salg av eiendommer og selskapsandeler.
Address
Krøderfjordveien 1411, 3536 Noresund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −114 | −114 | −114 | −114 |
| EBITDA | −238 | −411 | −462 | −498 | −332 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −238 | −411 | −462 | −498 | −332 |
| Net financials | 1 987 | 3 428 | −216 | 921 | 749 |
| Profit before tax | 1 749 | 3 016 | −678 | 423 | 417 |
| Tax | −12 | −64 | −0 | −0 | −0 |
| Net profit | 1 762 | 3 081 | −678 | 423 | 417 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 22 689 | 25 216 | 21 578 | 15 178 | 14 828 |
| Equity | 22 116 | 22 146 | 21 468 | 14 666 | 11 016 |
| Long-term debt | 64 | 0 | 0 | 0 | 0 |
| Short-term debt | 509 | 3 070 | 110 | 513 | 3 811 |
| Total debt | 573 | 3 070 | 110 | 513 | 3 811 |
EBITDA margin
-33248900.0%
This company
15.8%
Market median
-210436176% vs market
20202024
Equity ratio
74.3%
This company
38.2%
Market median
+95% vs market
20202024
Return on equity
3.8%
This company
18.4%
Market median
-79% vs market
20202024
Net profit margin
41681100.0%
This company
8.1%
Market median
+514581381% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IA Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEYER MED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inger Anne Smith-Meyer | Chief Executive Officer | 0 companies |
| Erik Smith-Meyer | Board of Directors | 0 companies |
| Bjørn Smith-Meyer | Board of Directors | 0 companies |
| Kristian Knudsen | Board of Directors | 0 companies |